Detection of distant metastases in head and neck cancer patients by whole body FDG-PET and whole body MRI

• Conditions: distant metastases; head and neck cancer; 10027476

• Registration Number: NL-OMON32960
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

head and neck cancer
high risk factors for distant metastases
candidate for extensive locoregional treatment with curative intent

Exclusion Criteria

known with distant metastases (no screening)

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary endpoints are the proportion of clinically relevant findings (detection<br /><br>of distant metastases) with MRI and/or PET/CT and the diagnostic accuracy of<br /><br>MRI, PET/CT and combination of MRI and PET/CT. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoint is the interobserver agreement of MRI and PET/CT. </p><br>